This enzyme requires vitamin B2
Methods This retrospective, database study used Optums de-identified Clinformatics Data Mart Database to identify glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment-nave adult patients with type 2 diabetes (T2D) initiating semaglutide QW, dulaglutide, liraglutide, or exenatide QW between January 1, 2018 and April 30, 2019
Each of these trials demonstrated the benefit of combination therapy, whereby combination of an SGLT2i and a RAAS inhibitor reduced the risk of progression or death from CV (or kidney) causes, CV events, and risk of kidney failure compared with RAAS inhibitor/standard of care alone [14,15,16]
Preclinical studies in animal models have demonstrated that survodutide effectively activates both GLP-1R and GCGR, resulting in reduced body weight, slower gastric emptying, decreased energy intake, increased energy expenditure, and improved glucose tolerance [86]
Mechanisms of Ageing and Development (PubMed) (2004) 9